-- 魯賓製藥（Lupin，NSE：LUPIN，BOM：500257）截至3月31日的第四財季合併歸屬於股東的淨利潤大幅增長至146億印度盧比，而去年同期為77.3億盧比。 這家製藥公司週四向印度證券交易所提交的文件顯示，每股收益為31.89盧比，高於去年同期的16.87盧比。 第四財季營業收入從去年同期的567億盧比增加至747億盧比。 公司董事會宣布，截至3月31日的財年，每股面額2盧比的普通股派發18盧比的股息，所有股息均已繳足。
Related Articles
Asia
GCL Technology Unit Raises $148 Million via Debt Offering
GCL Technology (HKG:3800) unit GCL Solar Star Investment completed a $148 million debt offering, the firm said in a Hong Kong filing Thursday.The solar materials manufacturer's shares were down over 2% in late morning trade Friday.The unit sold 6.95% guaranteed convertible bonds due 2027 that can be exchanged for shares of GCL Technology at an initial rate of HK$1.21 per conversion share.Assuming full conversion, the bonds would net 958.6 million GCL Technology shares, representing 2.80% of the business on an enlarged basis.The convertible bonds were listed in Vienna.Proceeds from the debt offering will be used for general corporate purposes and repayment of debts, GCL Technology said.
$HKG:3800
Asia
Lotus Horizon Expects Slide to Loss in Q1 2026
Lotus Horizon (HKG:6063) said it expects HK$3.5 million in consolidated net loss for the first quarter of 2026, compared with a profit of HK$3.2 million a year earlier, according to a Hong Kong filing Thursday.The construction engineering services firm's shares gained over 1% in Friday morning trade.The firm attributed the slide into loss to a 13% year-on-year decrease in revenue due to slow progress on construction projects.
$HKG:6063
Asia
Wiwynn Logs NT$14 Billion Profit in Q1; Shares Gain 5%
Wiwynn (TPE:6669) posted a net profit attributable to owners of NT$14.1 billion for the first quarter, or NT$75.95 per basic share, according to a Thursday disclosure on the Taiwan Exchange.Shares gained about 5% in Friday's afternoon trade.The manufacturer of cloud infrastructure products did not provide comparative year-ago figures.Operating revenue amounted to NT$276.5 billion, it said.
$TPE:6669